查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1924629

生物基微量吸管尖市场：按材料类型、吸头类型、吸头容量、应用、最终用户和分销管道划分 - 全球预测 2026-2032

BioBased Pipette Tips Market by Material Type, Tip Type, Tip Volume, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年生物基微量吸管尖市场价值为 7,047 万美元，预计到 2026 年将成长至 8,422 万美元，年复合成长率为 14.32%，到 2032 年将达到 1.7986 亿美元。

关键市场统计数据
基准年 2025 7047万美元
预计年份：2026年 8422万美元
预测年份 2032 1.7986亿美元
复合年增长率 (%) 14.32%

生物基微量吸管尖是一项深远的应用，它巧妙地整合了实验室性能、永续性目标和筹资策略等多个面向。

生物基微量吸管尖正逐渐成为满足实验室性能要求和组织永续性倡议的新兴选择。聚合物科学和精密成型技术的进步使得利用可再生原料製造吸头成为可能，同时也能维持实验过程所需的尺寸精度、低颗粒含量和化学相容性。推动其普及的因素既包括强调降低产品生命週期内环境影响的采购政策，也包括在高通量环境下减少一次性塑胶废弃物的营运需求。

对重塑永续移液器耗材的采用、采购和製造实践的多方面变革进行全面分析

移液器耗材的市场环境正经历变革性的转变，这项转变同时涵盖了技术、监管和商业性等多个面向。在技​​术方面，原料化学和挤出製程的改进缩小了生物基树脂与传统聚合物之间的性能差距，从而在严苛的应用环境中实现了持续的精度提升并降低了污染风险。这项进步降低了应用门槛，并促成了多中心评估的发展，这种评估强调的是等效性而非妥协。

深入分析美国贸易政策变化和关税调整对供应链策略、采购决策和采购风险评估的影响

在报告期间内，美国实施的关税调整、贸易政策变更和进口合规措施的累积影响，对生物基微量吸管尖供应链产生了复杂的连锁反应。关税变化改变了国产吸头和进口吸头之间的相对成本结构，引发了一系列下游应对措施，包括重新分配采购资源、修订供应商合约以及重新评估到岸成本假设。这些因应措施受到目前采购来源区域集中度的限制，尤其是在新型生物聚合物原料方面，导致成本对国际物流和供应商集中度高度敏感。

将材料科学、晶片设计、容量范围、应用特性、终端用户画像和分销动态等因素综合起来，形成一个全面的细分市场洞察，并整合到一个商业化蓝图中。

市场细分揭示了生物基微量吸管尖市场中性能预期、采购惯例和永续性优先事项的交汇点。从纤维素配方到聚丁二酸丁二醇酯衍生物、聚乳酸变体和淀粉增强复合材料，材料选择路径不仅决定了环境特性，还决定了加工需求、灭菌耐受性和化学相容性。这些材料特性与功能设计选择（例如是否带有过滤元件）相互交织。对于污染敏感型工作流程，带有过滤功能的吸头是首选；而对于以处理量和成本效益为首要考虑因素的应用，则更倾向于选择不带过滤功能的吸头。

区域差异化的采用模式和供应链现状影响着主要全球市场的采购、验证频率和本地製造优先事项。

区域趋势对生物基微量吸管尖的普及率、法规要求和供应链设计有显着影响。在美洲，机构永续性措施和集中采购框架往往主导着采购决策，这为能够展现生命週期优势、品质稳定和在地化服务能力的供应商创造了机会。北美地区的生产能力以及接近性大型研究中心的优势，有助于实现快速认证和缩短补货週期，而买家往往更看重这些优势，而非远距离供应商带来的微薄成本节省。

对生物基耗材领域现有企业、材料创新者及推动差异化及市场普及的整合供应链模式进行策略性竞争概述

生物基微量吸管尖市场的竞争格局呈现出多元化的特点，既有成熟的耗材製造商，也有专注于材料创新和以永续性为核心的参与企业。现有供应商的优势，例如丰富的品管系统经验、自动化相容性测试和广泛的分销网络，仍然是受监管买家关注的关键差异化因素。同时，灵活的新参与企业则利用其专有的生物聚合物配方技术、与树脂製造商的合作以及针对特定应用领域的检验项目，在不牺牲性能的前提下，优先考虑环境影响。

透过协调技术检验、建立具有韧性的供应链、采用分段式商业模式以及提供可靠的永续性资讯揭露，提出加速技术普及的实用策略建议。

为了将先导计画推进到更广泛的营运阶段，产业领导者应采取协作策略，整合产品开发、供应链设计和客户参与。首先，需要在代表性的工作流程和自动化平台上进行严格的效能检验，以证明其在准确性、污染控制和化学相容性方面的等效性。这些技术证据必须与第三方认证和文件结合，这些认证和文件应涵盖灭菌稳定性、可萃取物和批次可追溯性，以满足合规部门和采购委员会的要求。

进行了一项严谨的多方法研究，结合了相关人员访谈、技术检验审查以及贸易和采购分析，以支持基于证据的研究结果。

我们的研究途径结合了定性相关人员访谈、技术文献综述以及对监管和采购指南的系统性审查，以确保研究结果的平衡性和实证性。访谈对象包括实验室经理、采购人员、品质保证专家和生产主管，旨在了解不同终端使用者群体在营运挑战、验证要求和商业性偏好。我们透过白皮书、同行评审的生物聚合物在实验室环境中的行为研究以及供应商验证报告，对技术性能声明进行了交叉核对，以确保观察结果的一致性和可重复性。

本概要重点阐述了将生物基移液器耗材整合到常规实验室实践中的准备驱动因素、应用驱动因素和合作重点。

生物基微量吸管尖为实验室提供了兼顾性能要求和永续性目标的可行方案。关键材料类别的技术已足够成熟，足以支援在临床、科学研究和环境工作流程中进行严格评估。同时，供应链调整和监管关注正促使供应商将重点转向本地生产能力、可追溯的采购来源和有据可查的验证。加速推广应用将继续取决于供应商能否证明其操作等效性、支援自动化和灭菌要求，并提供符合机构采购标准的可靠生命週期资讯。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 生物基微量吸管尖市场（依材料类型划分）

  • 纤维素
  • PBS
  • PLA
  • 淀粉

9. 生物性微量吸管尖市场（以吸头类型划分）

  • 带过滤器
  • 非过滤型

第十章 生物性微量吸管尖市场（以吸头体积划分）

  • 10～200µL
  • 200～1000µL
  • 少于10微升
  • 超过 1000 微升

第十一章 生物基微量吸管尖市场（依应用划分）

  • 临床诊断
    • 血液学
    • 免疫学
    • 分子诊断
  • 药物发现
  • 环境测试
    • 空气检测
    • 土壤检测
    • 水质检测
  • 基因组学

第十二章 依最终用户分類的生物基微量吸管尖市场

  • 学术研究机构
  • 生技公司
  • 合约研究机构
  • 製药公司

第十三章 生物基微量吸管尖市场（依通路分割）

  • 线下零售
  • 线上零售

第十四章 生物性微量吸管尖市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 生物性微量吸管尖市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国生物基微量吸管尖市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

17. 美国生物基微量吸管尖市场

第十八章：中国生物基微量吸管尖市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Avantor Inc
  • Biotix Inc
  • BRAND GMBH+CO KG
  • Corning Incorporated
  • DLAB Scientific Co Ltd
  • Eppendorf SE
  • GenFollower Biotech CO Ltd
  • Gilson Inc
  • Greiner Bio-One International GmbH
  • Hamilton Company
  • Hirschmann Laborgerate GmbH & Co KG
  • INTEGRA Biosciences AG
  • Labcon North America
  • Merck KGaA
  • Mettler-Toledo International Inc
  • NEST Biotechnology Co Ltd
  • Ratiolab GmbH
  • Sartorius AG
  • Simport Scientific Inc
  • Socorex Isba SA
  • STARLAB International GmbH
  • Tecan Group Ltd
  • Thermo Fisher Scientific Inc
  • VWR International LLC
  • Zhejiang Biorear Biotechnology Co Ltd
Product Code: MRR-7A380DA7C3E4

The BioBased Pipette Tips Market was valued at USD 70.47 million in 2025 and is projected to grow to USD 84.22 million in 2026, with a CAGR of 14.32%, reaching USD 179.86 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 70.47 million
Estimated Year [2026] USD 84.22 million
Forecast Year [2032] USD 179.86 million
CAGR (%) 14.32%

High-impact introduction framing bio-based pipette tips as a pragmatic intersection of laboratory performance, sustainability goals, and procurement strategy

Bio-based pipette tips are emerging at the intersection of laboratory performance requirements and institutional sustainability commitments. Advances in polymer science and precision molding have made it possible to produce tips from renewable feedstocks while retaining the dimensional accuracy, low particulate burden, and chemical compatibility that laboratory workflows demand. Adoption is being driven both by procurement policies that favor lower lifecycle environmental impact and by operational imperatives to reduce single-use plastic waste in high-throughput environments.

As laboratories and corporate sustainability leads evaluate alternatives to conventional polypropylene, the conversation has shifted from proof-of-concept trials to integration strategies across clinical, research, and industrial settings. This introductory overview frames bio-based pipette tips as a pragmatic innovation: one that requires alignment across quality assurance, supply chain resilience, and user validation. The subsequent sections synthesize the structural shifts, regulatory influences, and segmentation dynamics that shape how these products are evaluated, procured, and scaled within contemporary laboratory ecosystems.

Comprehensive analysis of the multifaceted transformative shifts reshaping adoption, procurement, and manufacturing practices for sustainable pipette consumables

The landscape for pipette consumables is undergoing transformative shifts that are simultaneously technical, regulatory, and commercial. Technically, improvements in feedstock chemistry and extrusion-molding workflows have narrowed the performance delta between bio-based resins and traditional polymers, enabling sustained accuracy and reduced contamination risk in demanding applications. This progression has lowered barriers to adoption and enabled multi-site evaluations that emphasize equivalence rather than compromise.

Regulatory and institutional pressures are driving procurement toward materials with reduced embodied carbon and enhanced end-of-life profiles. Healthcare systems, academic consortia, and corporate research organizations are increasingly integrating environmental criteria into product specifications, procurement tenders, and capital planning. At the same time, buyers remain attentive to validations, lot traceability, and compatibility with automation platforms, creating a dual imperative for suppliers to demonstrate both sustainability credentials and operational reliability.

Commercially, supply chain resilience has become a decisive factor. Regional manufacturing capacity, vendor diversification, and validated secondary suppliers have grown in importance as laboratories seek to mitigate exposure to logistics disruptions and trade friction. These structural shifts are fostering strategic partnerships between established consumable manufacturers and newer materials innovators, and they are incentivizing investment in production scale-up, quality systems, and certified material sourcing.

In-depth assessment of how evolving United States trade policies and tariff adjustments have reshaped supply chain strategies, sourcing decisions, and procurement risk calculus

The cumulative impact of tariff adjustments, trade policy changes, and import compliance measures implemented by the United States during the referenced period has nuanced repercussions for supply chains of bio-based pipette tips. Tariff changes have altered relative cost dynamics between domestically produced tips and imports, prompting several downstream responses including sourcing reallocation, modification of supplier contracts, and re-evaluation of landed cost assumptions. These responses are tempered by the fact that raw material sourcing, particularly for novel bio-polymers, remains concentrated in specific regions, which preserves cost sensitivity to international logistics and supplier concentration.

Beyond direct cost effects, tariffs have influenced strategic investment decisions. Manufacturers with flexible production footprints have accelerated capital deployment to regionalize manufacturing, thereby reducing exposure to tariff volatility and improving lead-time reliability for laboratory customers. At the same time, some buyers have accepted slightly higher unit costs in exchange for shorter delivery windows and enhanced traceability, especially for regulated environments where continuity of supply is essential.

Import compliance burdens and evolving classification guidance have also pushed firms to invest in customs expertise and product documentation practices. These administrative adaptations improve the predictability of cross-border flows but add to supplier overheads that are often amortized across pricing models. Collectively, the tariff and trade environment has catalyzed a rebalancing toward supply chain resilience, regional capacity building, and stronger contractual protections against trade disruption, all of which shape how procurement teams evaluate total cost and operational risk.

Holistic segmentation insights connecting material science, tip design, volume ranges, application specificity, end-user profiles, and distribution dynamics into an integrated commercialization roadmap

Segmentation illuminates where performance expectations, procurement practices, and sustainability priorities converge within the bio-based pipette tips landscape. Material selection pathways-ranging from cellulose-based formulations to polybutylene succinate derivatives, polylactic acid variants, and starch-enhanced composites-define not only environmental profiles but also processing requirements, sterilization tolerance, and chemical compatibility. These material characteristics intersect with functional design choices such as the presence or absence of a filter element, where filtered tips are prioritized for contamination-sensitive workflows and non-filtered options are favored where throughput and cost efficiency dominate.

Volume range considerations further differentiate product development and customer selection. Very low volume tips for microfluidics and single-cell genomics require ultra-fine manufacturing tolerances and low adsorption surfaces, midrange volumes align with routine bench work and automated liquid-handling platforms, and high-capacity tips for bulk transfers demand reinforced construction and ergonomic design. Application contexts provide another critical axis of segmentation: clinical diagnostics imposes rigorous validation regimes across hematology, immunology, and molecular diagnostics; drug discovery emphasizes reproducibility, compatibility with robotics, and low carryover; environmental testing demands chemical resistance and rugged performance across air, soil, and water matrices; and genomics pushes the frontier on low-bind surfaces and nucleic acid preservation.

End-user profiles shape procurement cadence, validation requirements, and purchasing volumes. Academic research institutes often prioritize cost-effective trials and flexible supplier arrangements, biotechnology companies value innovation partnership and lot-to-lot consistency, contract research organizations demand scalable supply with traceable quality systems, and pharmaceutical companies emphasize compliance, long-term contracts, and technical support for regulatory submissions. Distribution channels mediate the buyer experience: direct sales enable tailored contracts and integrated service offerings, distributors add reach and local inventory buffering for diverse customer segments, and online retail introduces convenience and faster transactional purchasing for smaller orders. Taken together, these segmentation axes reveal differentiated pathways to commercial adoption and highlight where suppliers must align material science, manufacturing precision, validation documentation, and channel strategy to meet distinct laboratory needs.

Regionally differentiated adoption patterns and supply chain realities shaping procurement, validation cadence, and local manufacturing priorities across key global markets

Regional dynamics exert a strong influence on adoption velocity, regulatory expectations, and supply chain design for bio-based pipette tips. In the Americas, purchasing decisions are frequently driven by institutional sustainability commitments and centralized procurement frameworks, creating opportunities for suppliers that can demonstrate lifecycle benefits alongside consistent quality and local service capabilities. North American manufacturing capacity and proximity to large research hubs support rapid qualification cycles and shorter replenishment times, which buyers often value more highly than marginal cost savings from distant suppliers.

Across Europe, Middle East & Africa the regulatory landscape and extended public procurement mechanisms create both constraints and incentives for sustainable product adoption. Certification frameworks, extended producer responsibility considerations, and cross-border logistics within the region influence how suppliers present environmental credentials and compliance documentation. In several countries, governmental procurement preferences for lower carbon alternatives expedite trials and scale-up in clinical and academic institutions.

The Asia-Pacific region demonstrates particularly heterogeneous demand patterns driven by substantial investment in life sciences infrastructure, manufacturing capacity, and rapidly expanding clinical research activity. Local production hubs in parts of Asia-Pacific have accelerated access to bio-based resin technologies while regional buyers balance cost sensitivity with rising expectations for validated performance and automation compatibility. Overall, suppliers that tailor commercial models to regional regulatory norms, supply chain realities, and procurement behaviors are best positioned to secure long-term engagements across these diverse geographies.

Strategic competitive overview highlighting how incumbents, materials innovators, and integrated supply approaches drive differentiation and adoption in the bio-based consumables space

Competitive dynamics within the bio-based pipette tip ecosystem are characterized by a blend of established consumables manufacturers, specialized materials innovators, and emerging challengers focused on sustainability credentials. Incumbent suppliers benefit from deep experience in quality management systems, automation compatibility testing, and broad distribution networks, which remain important differentiators for regulated buyers. At the same time, nimble entrants are leveraging proprietary bio-polymer formulations, partnerships with resin producers, and focused validation programs to target niche applications that value reduced environmental impact without sacrificing performance.

Strategic positioning varies across firms: some are investing in vertical integration to control feedstock quality and manufacturing yield, while others prioritize certification and third-party testing to accelerate acceptance among conservative laboratory buyers. Collaborative models-where materials companies work alongside original equipment manufacturers to co-develop tooling and process controls-are increasingly common and help mitigate scale-up risk. Moreover, commercial success often hinges on the ability to supply robust technical documentation, facilitate automation compatibility trials, and provide responsive post-sales support that addresses lot traceability and sterilization validation. Companies that combine proven quality systems, transparent sustainability metrics, and flexible fulfillment options tend to attract larger institutional contracts and repeat business.

Actionable strategic recommendations for aligning technical validation, resilient supply chains, segment-specific commercial models, and credible sustainability disclosure to accelerate adoption

Industry leaders must pursue a coordinated strategy that aligns product development, supply chain design, and customer engagement to convert pilot projects into broad operational adoption. First, invest in rigorous performance validation across representative workflows and automation platforms to demonstrate equivalence in accuracy, contamination control, and chemical compatibility. This technical evidence should be coupled with third-party certifications and documentation that address sterilization stability, extractables, and lot traceability to satisfy compliance teams and procurement committees.

Second, prioritize supply chain resilience through regional capacity expansion, qualified dual sourcing of key resin feedstocks, and strengthened logistics partnerships. Buyers increasingly value shorter lead times and predictable replenishment over marginal unit cost reductions, so operational reliability is a competitive advantage. Third, tailor commercial models to end-user segments: offer scaled evaluation programs for academic labs, flexible volume contracts for biotech firms, and validated supply agreements for pharmaceutical and contract research organizations. Supplement these offerings with educational resources and hands-on support to help laboratory staff transition to bio-based consumables with minimal workflow disruption.

Finally, integrate credible environmental metrics into product positioning while avoiding unverified claims. Lifecycle assessment results, end-of-life guidance, and transparent sourcing information resonate with sustainability officers and procurement teams when presented alongside robust quality validations. Executing on these priorities will increase confidence among institutional purchasers and reduce friction during qualification cycles.

Robust multi-method research design combining stakeholder interviews, technical validation review, and trade and procurement analysis to underpin evidence-based insights

The research approach combined qualitative stakeholder interviews, technical literature synthesis, and a systematic review of regulatory and procurement guidance to ensure balanced, evidence-based findings. Interviews targeted laboratory managers, procurement leaders, quality assurance specialists, and manufacturing executives to capture operational pain points, validation requirements, and commercial preferences across diverse end-user segments. Technical performance claims were cross-checked against white papers, peer-reviewed studies on bio-polymer behavior in laboratory contexts, and supplier validation reports to ensure consistency and reproducibility of observations.

Supply chain and trade implications were analyzed through customs classification materials, public policy announcements, and logistics trend reports. Regional adoption patterns were evaluated by combining institutional procurement tendencies with observable manufacturing footprints and academic research activity. The methodology emphasized triangulation of multiple data sources and conservative interpretation of qualitative inputs to produce actionable insights while maintaining methodological transparency.

Concise concluding synthesis highlighting readiness drivers, adoption enablers, and collaborative priorities for integrating bio-based pipette consumables into routine laboratory practice

Bio-based pipette tips present a pragmatic pathway for laboratories seeking to reconcile performance needs with sustainability ambitions. The technology has matured sufficiently in key material families to support rigorous evaluation across clinical, research, and environmental workflows, while supply chain adjustments and regulatory attention have shifted supplier priorities toward regional capacity, traceable sourcing, and documented validation. Adoption will continue to be driven by the ability of suppliers to demonstrate operational equivalence, to support automation and sterilization requirements, and to provide credible lifecycle information that aligns with institutional procurement criteria.

Ultimately, widespread integration will depend on collaborative efforts across material scientists, manufacturers, and laboratory stakeholders to reduce qualification friction and to codify best practices for use, disposal, and performance verification. When these elements align, bio-based pipette tips can deliver environmental benefits without compromising the precision and reliability laboratories demand.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. BioBased Pipette Tips Market, by Material Type

  • 8.1. Cellulose
  • 8.2. Pbs
  • 8.3. Pla
  • 8.4. Starch

9. BioBased Pipette Tips Market, by Tip Type

  • 9.1. Filtered
  • 9.2. Non-Filtered

10. BioBased Pipette Tips Market, by Tip Volume

  • 10.1. 10-200 µL
  • 10.2. 200-1000 µL
  • 10.3. <10 µL
  • 10.4. >1000 µL

11. BioBased Pipette Tips Market, by Application

  • 11.1. Clinical Diagnostics
    • 11.1.1. Hematology
    • 11.1.2. Immunology
    • 11.1.3. Molecular Diagnostics
  • 11.2. Drug Discovery
  • 11.3. Environmental Testing
    • 11.3.1. Air Testing
    • 11.3.2. Soil Testing
    • 11.3.3. Water Testing
  • 11.4. Genomics

12. BioBased Pipette Tips Market, by End User

  • 12.1. Academic Research Institutes
  • 12.2. Biotechnology Companies
  • 12.3. Contract Research Organizations
  • 12.4. Pharmaceutical Companies

13. BioBased Pipette Tips Market, by Distribution Channel

  • 13.1. Offline Retail
  • 13.2. Online Retail

14. BioBased Pipette Tips Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. BioBased Pipette Tips Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. BioBased Pipette Tips Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States BioBased Pipette Tips Market

18. China BioBased Pipette Tips Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Avantor Inc
  • 19.6. Biotix Inc
  • 19.7. BRAND GMBH + CO KG
  • 19.8. Corning Incorporated
  • 19.9. DLAB Scientific Co Ltd
  • 19.10. Eppendorf SE
  • 19.11. GenFollower Biotech CO Ltd
  • 19.12. Gilson Inc
  • 19.13. Greiner Bio-One International GmbH
  • 19.14. Hamilton Company
  • 19.15. Hirschmann Laborgerate GmbH & Co KG
  • 19.16. INTEGRA Biosciences AG
  • 19.17. Labcon North America
  • 19.18. Merck KGaA
  • 19.19. Mettler-Toledo International Inc
  • 19.20. NEST Biotechnology Co Ltd
  • 19.21. Ratiolab GmbH
  • 19.22. Sartorius AG
  • 19.23. Simport Scientific Inc
  • 19.24. Socorex Isba SA
  • 19.25. STARLAB International GmbH
  • 19.26. Tecan Group Ltd
  • 19.27. Thermo Fisher Scientific Inc
  • 19.28. VWR International LLC
  • 19.29. Zhejiang Biorear Biotechnology Co Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOBASED PIPETTE TIPS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOBASED PIPETTE TIPS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP VOLUME, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES BIOBASED PIPETTE TIPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA BIOBASED PIPETTE TIPS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY CELLULOSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY CELLULOSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY CELLULOSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY PBS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY PBS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY PBS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY PLA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY PLA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY PLA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY STARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY STARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY STARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY FILTERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY FILTERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY FILTERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY NON-FILTERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY NON-FILTERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY NON-FILTERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP VOLUME, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY 10-200 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY 10-200 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY 10-200 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY 200-1000 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY 200-1000 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY 200-1000 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY <10 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY <10 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY <10 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY >1000 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY >1000 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY >1000 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY AIR TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY AIR TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY AIR TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY SOIL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY SOIL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY SOIL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY WATER TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY WATER TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY WATER TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY OFFLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY OFFLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BIOBASED PIPETTE TIPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BIOBASED PIPETTE TIPS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP VOLUME, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS BIOBASED PIPETTE TIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS BIOBASED PIPETTE TIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS BIOBASED PIPETTE TIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BIOBASED PIPETTE TIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BIOBASED PIPETTE TIPS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP VOLUME, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA BIOBASED PIPETTE TIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA BIOBASED PIPETTE TIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA BIOBASED PIPETTE TIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BIOBASED PIPETTE TIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BIOBASED PIPETTE TIPS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP VOLUME, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA BIOBASED PIPETTE TIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA BIOBASED PIPETTE TIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA BIOBASED PIPETTE TIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BIOBASED PIPETTE TIPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BIOBASED PIPETTE TIPS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP VOLUME, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA BIOBASED PIPETTE TIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA BIOBASED PIPETTE TIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA BIOBASED PIPETTE TIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BIOBASED PIPETTE TIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BIOBASED PIPETTE TIPS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP VOLUME, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE BIOBASED PIPETTE TIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE BIOBASED PIPETTE TIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE BIOBASED PIPETTE TIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BIOBASED PIPETTE TIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BIOBASED PIPETTE TIPS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP VOLUME, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST BIOBASED PIPETTE TIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST BIOBASED PIPETTE TIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST BIOBASED PIPETTE TIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA BIOBASED PIPETTE TIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA BIOBASED PIPETTE TIPS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP VOLUME, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA BIOBASED PIPETTE TIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA BIOBASED PIPETTE TIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA BIOBASED PIPETTE TIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC BIOBASED PIPETTE TIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC BIOBASED PIPETTE TIPS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP VOLUME, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC BIOBASED PIPETTE TIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC BIOBASED PIPETTE TIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC BIOBASED PIPETTE TIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN BIOBASED PIPETTE TIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN BIOBASED PIPETTE TIPS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP VOLUME, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN BIOBASED PIPETTE TIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN BIOBASED PIPETTE TIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN BIOBASED PIPETTE TIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. GCC BIOBASED PIPETTE TIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GCC BIOBASED PIPETTE TIPS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. GCC BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP VOLUME, 2018-2032 (USD MILLION)
  • TABLE 175. GCC BIOBASED PIPETTE TIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. GCC BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 177. GCC BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 178. GCC BIOBASED PIPETTE TIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GCC BIOBASED PIPETTE TIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION BIOBASED PIPETTE TIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION BIOBASED PIPETTE TIPS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP VOLUME, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION BIOBASED PIPETTE TIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION BIOBASED PIPETTE TIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION BIOBASED PIPETTE TIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS BIOBASED PIPETTE TIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS BIOBASED PIPETTE TIPS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP VOLUME, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS BIOBASED PIPETTE TIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS BIOBASED PIPETTE TIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS BIOBASED PIPETTE TIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. G7 BIOBASED PIPETTE TIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. G7 BIOBASED PIPETTE TIPS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. G7 BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP VOLUME, 2018-2032 (USD MILLION)
  • TABLE 202. G7 BIOBASED PIPETTE TIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. G7 BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 204. G7 BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 205. G7 BIOBASED PIPETTE TIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. G7 BIOBASED PIPETTE TIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. NATO BIOBASED PIPETTE TIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. NATO BIOBASED PIPETTE TIPS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. NATO BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. NATO BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP VOLUME, 2018-2032 (USD MILLION)
  • TABLE 211. NATO BIOBASED PIPETTE TIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. NATO BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 213. NATO BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 214. NATO BIOBASED PIPETTE TIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. NATO BIOBASED PIPETTE TIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL BIOBASED PIPETTE TIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES BIOBASED PIPETTE TIPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES BIOBASED PIPETTE TIPS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP VOLUME, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES BIOBASED PIPETTE TIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES BIOBASED PIPETTE TIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES BIOBASED PIPETTE TIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA BIOBASED PIPETTE TIPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA BIOBASED PIPETTE TIPS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA BIOBASED PIPETTE TIPS MARKET SIZE, BY TIP VOLUME, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA BIOBASED PIPETTE TIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA BIOBASED PIPETTE TIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA BIOBASED PIPETTE TIPS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA BIOBASED PIPETTE TIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA BIOBASED PIPETTE TIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)